AI leaders urge Congress to mandate synthetic DNA order screening

Read the original article →

What happened

A coalition of AI leaders, biotech executives, scientists and national security officials sent a letter to U.S. lawmakers on June 15 calling for legislation on synthetic DNA and RNA. It asks Congress to require companies that produce synthetic genetic material to screen every order, verify customers and keep buyer records. Signatories include the CEOs of Google DeepMind, Anthropic, Microsoft AI and OpenAI, plus Nobel laureates.

The letter argues that rapid AI advances could erode the knowledge barriers that have historically prevented bad actors from accessing bioweapons capability. It notes that industry formed the voluntary International Gene Synthesis Consortium in 2009, and urges Congress to act this session while states align with federal guidelines.

Why it matters

Synthetic DNA synthesis is a chokepoint where screening can meaningfully limit misuse. Moving from a voluntary consortium to a legal mandate would close gaps left by providers who do not participate.

It is also notable that direct competitors in AI are jointly asking to be regulated in an area tied to their own technology.

MintedBrain take

Self-regulation letters can shape rules that follow, so it is worth watching what the eventual legislation actually requires rather than the headline ask. For anyone building in bio-adjacent AI, screening and record-keeping obligations may become table stakes, and planning for them early is prudent.

References

This article was originally published at ScreenDNA (letter). For the full piece, read the original article.

Discussion

  • Loading…

← Back to News